Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

High Glucose Contribution to the TCA Cycle Is a Feature of Aggressive Non–Small Cell Lung Cancer in Patients

Cancer Discovery(2025)10.1158/2159-8290.cd-23-1319Source: DataRank Database

High Glucose Contribution to the TCA Cycle Is a Feature of Aggressive Non–Small Cell Lung Cancer in Patients is a research paper published in Cancer Discovery (2025). On theSindex it has a DataRank of 0.425. It has been cited 16 times.

N/A

0.425DataRank · unranked

Scored on demand from live citation data

Open Access16 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)Impact (FWCI 7.44)OA: hybridTopics (29)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.425

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (45)

Nia G. Hammond ORCID,Alpaslan Tasdogan ORCID,Massar Alsamraae ORCID,Chendong Yang ORCID,Robert B. Cameron ORCID

Live enrichment

PubMed:39960461 OpenAlex:https://openalex.org/W4407641714

National Cancer Institute

Grant: R35CA220449

National Cancer Institute

Grant: R00CA237724

National Cancer Institute

Grant: R01CA285336

Deutsche Forschungsgemeinschaft

Grant: 467788900

Ministry of Culture and Science of the State of North Rhine-Westphalia

Grant: Nachwuchsgruppenprogramm

National Cancer Institute

Grant: T32-009594

National Cancer Institute

Grant: P50 CA70907

National Institutes of Health

Grant: P41 EB015908

National Institutes of Health

Grant: UL1 TR001105

National Cancer Institute

Grant: 1P30 CA142543-01

National Cancer Institute

Grant: P30CA014599

FWCI

7.44

Citation Percentile

1.0%

Citation Trend

2025

2026

hybridLicense: cc-by

journalhttps://aacrjournals.org/cancerdiscovery/article-pdf/doi/10.1158/2159-8290.CD-23-1319/3542079/cd-23-1319.pdf

publisherhttps://aacrjournals.org/cancerdiscovery/article-pdf/doi/10.1158/2159-8290.CD-23-1319/3542079/cd-23-1319.pdf

publisherhttps://aacrjournals.org/cancerdiscovery/article-pdf/15/4/702/3562520/cd-23-1319.pdf

journalhttps://doi.org/10.1158/2159-8290.cd-23-1319

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39960461

Fields of Study

Cancer, Hypoxia, and MetabolismLung Cancer Treatments and MutationsCancer, Lipids, and Metabolism

MeSH Terms

AnimalsCarcinoma, Non-Small-Cell LungCitric Acid CycleGlucoseHumansLung NeoplasmsCell Line, TumorMice

Keywords

Citric acid cycleMetastasisCancer researchBlockadeCancerLung cancerCell cycleMedicineGlycolysisTricarboxylic acidApoptosisLungInternal medicineMetabolismBiologyPathologyBiochemistryReceptor

Sustainable Development Goals

SDG 0: Good health and well-being